Nucleoside Analogue Reverse Transcriptase Inhibitors Improve Clinical Outcome in Transcriptional Active Human Parvovirus B19-Positive Patients

Schultheiss, Heinz-Peter; Bock, Thomas; Pietsch, Heiko; Aleshcheva, Ganna; Baumeier, Christian; Fruhwald, Friedrich; Escher, Felicitas

dc.contributor.author	Bock, Thomas
dc.date.accessioned	2021-12-27T08:57:57Z
dc.date.available	2021-12-27T08:57:57Z
dc.date.issued	2021
dc.identifier.issn	2077-0383
dc.identifier.uri	http://hdl.handle.net/10900/122159
dc.language.iso	en	de_DE
dc.publisher	Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/jcm10091928	de_DE
dc.subject.ddc	610	de_DE
dc.title	Nucleoside Analogue Reverse Transcriptase Inhibitors Improve Clinical Outcome in Transcriptional Active Human Parvovirus B19-Positive Patients	de_DE
dc.type	Article	de_DE
utue.quellen.id	20210824232002_01423
utue.personen.roh	Schultheiss, Heinz-Peter
utue.personen.roh	Bock, Thomas
utue.personen.roh	Pietsch, Heiko
utue.personen.roh	Aleshcheva, Ganna
utue.personen.roh	Baumeier, Christian
utue.personen.roh	Fruhwald, Friedrich
utue.personen.roh	Escher, Felicitas
dcterms.isPartOf.ZSTitelID	Journal of Clinical Medicine	de_DE
dcterms.isPartOf.ZS-Issue	Article 1928	de_DE
dcterms.isPartOf.ZS-Volume	10 (9)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE